The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 13, 2018

Filed:

Sep. 02, 2014
Applicant:

Amyris, Inc., Emeryville, CA (US);

Inventors:

Timothy Stevens Gardner, Emeryville, CA (US);

Kristy Michelle Hawkins, Emeryville, CA (US);

Adam Leon Meadows, Emeryville, CA (US);

Annie Ening Tsong, Emeryville, CA (US);

Yoseph Tsegaye, Emeryville, CA (US);

Assignee:

AMYRIS, INC., Emeryville, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12P 5/00 (2006.01); C12P 23/00 (2006.01); C12N 15/52 (2006.01); C12N 9/04 (2006.01); C12N 9/02 (2006.01); C12N 9/12 (2006.01); C12N 15/81 (2006.01); C12P 7/42 (2006.01);
U.S. Cl.
CPC ...
C12P 5/007 (2013.01); C12N 9/0006 (2013.01); C12N 9/0008 (2013.01); C12N 9/1288 (2013.01); C12N 15/52 (2013.01); C12N 15/81 (2013.01); C12P 7/42 (2013.01); C12P 23/00 (2013.01); C12Y 101/01034 (2013.01); C12Y 102/0101 (2013.01); C12Y 207/08 (2013.01);
Abstract

Provided herein are compositions and methods for the heterologous production of acetyl-CoA-derived isoprenoids in a host cell. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding an acetaldehyde dehydrogenase, acetylating (ADA, E.C. 1.2.1.10) and an MEV pathway comprising an NADH-using HMG-CoA reductase. In some embodiments, the host cell is genetically modified to comprise a heterologous nucleotide sequence encoding an ADA and an MEV pathway comprising an acetoacetyl-CoA synthase. In some embodiments, the genetically modified host cell further comprises one or more heterologous nucleotide sequences encoding a phosphoketolase and a phosphotransacetylase. In some embodiments, the genetically modified host cell further comprises a functional disruption of the native PDH-bypass. The compositions and methods described herein provide an energy-efficient yet redox balanced route for the heterologous production of acetyl-CoA-derived isoprenoids.


Find Patent Forward Citations

Loading…